Lichao Sun
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
- Cancer Cells and Metastasis
Papers in
-
- Cancer-related gene regulation 6
- Oncology 20
- Cancer Cells and Metastasis 11
- HER2/EGFR in Cancer Research 5
- Peptidase Inhibition and Analysis 5
- Co-authors
- Yuliang Ran (27 shared papers)Long Yu (12 shared papers)Lixin Sun (11 shared papers)Zhihua Yang (7 shared papers)Xiong Shu (9 shared papers)Jian Pan (10 shared papers)Joseph Burnett (11 shared papers)Duxin Sun (11 shared papers)
- Journals
- International Journal of Medical Sciences (3 papers)Cell Death Discovery (2 papers)International Journal of Oncology (2 papers)Oncotarget (2 papers)BMC Cancer (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Lichao Sun
47 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 101
- Cancer Research 343
- Oncology 335
- Molecular Biology 603
- Immunology and Allergy 51
- Immunology 107
Countries citing papers authored by Lichao Sun
This map shows the geographic impact of Lichao Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lichao Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lichao Sun more than expected).
Fields of papers citing papers by Lichao Sun
This network shows the impact of papers produced by Lichao Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lichao Sun. The network helps show where Lichao Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Lichao Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 75 | |
| 2 | 2009 | 71 | |
| 3 | 2011 | 59 | |
| 4 | 2022 | 59 | |
| 5 | 2015 | 54 | |
| 6 | 2008 | 53 | |
| 7 | 2017 | 48 | |
| 8 | 2021 | 44 | |
| 9 | 2021 | 40 | |
| 10 | 2012 | 40 | |
| 11 | 2016 | 39 | |
| 12 | 2016 | 31 | |
| 13 | CPA4 is a promising diagnostic serum biomarker for pancreatic cancer. | 2016 | 31 |
| 14 | 2017 | 28 | |
| 15 | Overexpression of carboxypeptidase A4 (CPA4) is associated with poor prognosis in patients with gastric cancer. | 2016 | 26 |
| 16 | 2021 | 25 | |
| 17 | 2019 | 25 | |
| 18 | 2016 | 23 | |
| 19 | 2012 | 22 | |
| 20 | Tumor endothelial cells promote metastasis and cancer stem cell-like phenotype through elevated Epiregulin in esophageal cancer. | 2016 | 22 |
About Lichao Sun
Lichao Sun is a scholar working on Molecular Biology, Oncology, Cancer Research, Biomedical Engineering and Epidemiology, having authored 49 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (11 papers), Cancer, Hypoxia, and Metabolism (8 papers), Cancer-related gene regulation (6 papers), HER2/EGFR in Cancer Research (5 papers), Peptidase Inhibition and Analysis (5 papers), Cancer Research and Treatments (4 papers), Lignin and Wood Chemistry (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (343 citations), Oncology (335 citations), Molecular Biology (603 citations), Immunology and Allergy (51 citations) and Immunology (107 citations). Lichao Sun has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Yuliang Ran, Long Yu, Lixin Sun, Zhihua Yang, Xiong Shu, Jian Pan, Joseph Burnett, Duxin Sun, Zhihua Yang and Chunguang Guo. Their work appears in journals such as International Journal of Medical Sciences, Cell Death Discovery, International Journal of Oncology, Oncotarget and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.